Regulacje i polityka gospodarcza · 31/10/2000

Novo Nordisk to Grant Exclusive License for Insulin-Producing Cells Differentiated by GLP-1 and Exendin-4

Novo Nordisk is set to grant an exclusive license for insulin-producing cells differentiated from non-insulin-producing cells by GLP-1 and Exendin-4, following a correction to its original proposal.

Source: Federal Register — All DocumentsOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Regulacje i polityka gospodarcza · 10/14/2026

Department of War Requests Comments on Proposed Manual for Courts-Martial Amendments

The Department of War (DoW) is seeking comments on proposed changes to the Manual for Courts-Martial (MCM) and has announced a public meeting to receive comments on the changes.

Read summary →